Free Trial
NYSE:OGEN

Oragenics (OGEN) Stock Price, News & Analysis

Oragenics logo
$1.11 +0.03 (+2.78%)
Closing price 08/22/2025 03:58 PM Eastern
Extended Trading
$1.10 -0.01 (-0.45%)
As of 08/22/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Oragenics Stock (NYSE:OGEN)

Key Stats

Today's Range
$1.07
$1.13
50-Day Range
$1.06
$4.37
52-Week Range
$1.03
$40.80
Volume
57,164 shs
Average Volume
326,599 shs
Market Capitalization
$4.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oragenics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

OGEN MarketRank™: 

Oragenics scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Oragenics.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oragenics is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oragenics is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Oragenics has a P/B Ratio of 1.82. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.10% of the float of Oragenics has been sold short.
  • Short Interest Ratio / Days to Cover

    Oragenics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oragenics has recently decreased by 28.09%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Oragenics does not currently pay a dividend.

  • Dividend Growth

    Oragenics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.10% of the float of Oragenics has been sold short.
  • Short Interest Ratio / Days to Cover

    Oragenics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oragenics has recently decreased by 28.09%, indicating that investor sentiment is improving significantly.
  • MarketBeat Follows

    Only 2 people have added Oragenics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oragenics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.90% of the stock of Oragenics is held by insiders.

  • Percentage Held by Institutions

    Only 18.71% of the stock of Oragenics is held by institutions.

  • Read more about Oragenics' insider trading history.
Receive OGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter.

OGEN Stock News Headlines

Oragenics (NYSE:OGEN) Stock Price Down 1.7% - Should You Sell?
Oragenics Q2 2025 Shareholder Update
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.tc pixel
See More Headlines

OGEN Stock Analysis - Frequently Asked Questions

Oragenics' stock was trading at $11.0790 at the beginning of the year. Since then, OGEN stock has decreased by 90.0% and is now trading at $1.11.

Oragenics, Inc. (NYSE:OGEN) announced its quarterly earnings results on Monday, August, 16th. The company reported ($54.00) earnings per share for the quarter, topping the consensus estimate of ($72.00) by $18.00.

Oragenics's stock reverse split on the morning of Monday, January 23rd 2023.The 1-60 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Top institutional investors of Oragenics include Clear Street LLC (8.58%) and Bank of America Corp DE (1.89%). Insiders that own company stock include Fred Telling, Alan W Dunton and Robert C Koski.
View institutional ownership trends
.

Shares of OGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oragenics investors own include Tonix Pharmaceuticals (TNXP), Onconova Therapeutics (ONTX), iBio (IBIO), Jaguar Animal Health (JAGX), NIO (NIO), Bionano Genomics (BNGO) and Vaxart (VXRT).

Company Calendar

Last Earnings
8/16/2021
Today
8/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:OGEN
Previous Symbol
NYSE:OGEN
CIK
1174940
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($21.42)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.66 million
Net Margins
N/A
Pretax Margin
-243,950.00%
Return on Equity
-2,087.95%
Return on Assets
-486.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.93
Quick Ratio
1.93

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.61 per share
Price / Book
1.82

Miscellaneous

Outstanding Shares
4,127,000
Free Float
10,979,000
Market Cap
$4.58 million
Optionable
N/A
Beta
0.65
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:OGEN) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners